Clinical Trial Update: Effect of rhIL-11 in Patients With Thrombocytopenia for Childhood ALL [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating recombinant human interleukin-11 for chemotherapy-induced thrombocytopenia in children with acute lymphoblastic leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Pancytopenia

Drugs mentioned

• rhIL-11 (recombinant human interleukin-11)

Snippet

Sponsor: Shanghai Children's Medical Center | Conditions: Pancytopenia Due to Chemotherapy | Phase 4 | Status: COMPLETED